» Authors » Marie-Noelle Mevelec

Marie-Noelle Mevelec

Explore the profile of Marie-Noelle Mevelec including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 197
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aljieli M, Riviere C, Lantier L, Moire N, Lakhrif Z, Boussemart A, et al.
Cells . 2024 Jun; 13(11. PMID: 38891106
holds significant therapeutic potential; however, its nonspecific invasiveness results in off-target effects. The purpose of this study is to evaluate whether specificity can be improved by surface display of scFv...
2.
Battistoni A, Lantier L, di Tommaso A, Ducournau C, Lajoie L, Samimi M, et al.
J Immunother Cancer . 2023 May; 11(5). PMID: 37192784
Background: Metastases are the leading cause of mortality in many cancer types and lungs are one of the most common sites of metastasis alongside the liver, brain, and bones. In...
3.
Allahyari M, Golkar M, Fard-Esfahani P, Dimier-Poisson I, Mevelec M
Microb Pathog . 2021 Nov; 162:105312. PMID: 34826553
Although vaccination is a promising approach for the control of toxoplasmosis, there is currently no commercially available human vaccine. Adjuvants such as delivery vehicles and immunomodulators are critical components of...
4.
di Tommaso A, Juste M, Lakhrif Z, Mevelec M, Borowczyk C, Hammeni P, et al.
J Infect Dis . 2021 Mar; 224(4):705-714. PMID: 33728452
Maternal-fetal transmission of Toxoplasma gondii tachyzoites acquired during pregnancy has potentially dramatic consequences for the fetus. Current reference-standard treatments are not specific to the parasite and can induce severe side...
5.
Mevelec M, Lakhrif Z, Dimier-Poisson I
Front Cell Infect Microbiol . 2020 Dec; 10:607198. PMID: 33324583
Toxoplasmosis is a parasitic disease affecting human, livestock and cat. Prophylactic strategies would be ideal to prevent infection. In a One Health vaccination approach, the objectives would be the prevention...
6.
Lantier L, Poupee-Beauge A, di Tommaso A, Ducournau C, Epardaud M, Lakhrif Z, et al.
J Immunother Cancer . 2020 Dec; 8(2). PMID: 33257408
Background: Microorganisms that can be used for their lytic activity against tumor cells as well as inducing or reactivating antitumor immune responses are a relevant part of the available immunotherapy...
7.
Cnudde T, Lakhrif Z, Bourgoin J, Boursin F, Horiot C, Henriquet C, et al.
Antibodies (Basel) . 2020 Apr; 9(2). PMID: 32326443
In order to increase the successful development of recombinant antibodies and fragments, it seems fundamental to enhance their expression and/or biophysical properties, such as the thermal, chemical, and pH stabilities....
8.
Lakhrif Z, Moreau A, Herault B, Di-Tommaso A, Juste M, Moire N, et al.
Front Immunol . 2018 Mar; 9:317. PMID: 29515595
Toxoplasmosis is a major public health problem and the development of a human vaccine is of high priority. Efficient vaccination against requires both a mucosal and systemic Th1 immune response....
9.
Rashid I, Moire N, Heraut B, Dimier-Poisson I, Mevelec M
Med Microbiol Immunol . 2016 Oct; 206(1):53-62. PMID: 27757545
Infection with the parasite Toxoplasma gondii causes serious public health problems and is of great economic importance worldwide. No vaccine is currently available, so the design of efficient vaccine strategies...
10.
Mevelec M, Ducournau C, Ismael A, Olivier M, Seche E, Lebrun M, et al.
Vet Res . 2010 Apr; 41(4):49. PMID: 20385082
This study assessed the effectiveness of a mutant strain of Toxoplasma gondii (RH strain) lacking the mic1 and mic3 genes (Mic1-3KO) against Toxoplasma abortion in sheep. Ewes were inoculated subcutaneously...